Abstract
The radiosynthesis of a novel tropane derivative [123I]KUC-25019, [[123I] N-(3-iodoprop-(2E)-enyl)-2α-(imino-methyl)-3β (3′,4′-dichlorophenyl)nortropane], a potential inhibitor of the dopamine transporter is reported. The synthetic routes include the preparation of standard reference, the stannyl precursor and the 123I-labeling synthesis. The no-carrier-added 123I-labeling has about 20% yield, the specific activity of [123I]KUC-25019 is > 107 GBq/μmol and the radiochemical purity of [123I] KUC-25019 is >95%.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1011-1017 |
| Number of pages | 7 |
| Journal | Journal of Labelled Compounds and Radiopharmaceuticals |
| Volume | 45 |
| Issue number | 12 |
| DOIs | |
| State | Published - Oct 30 2002 |
Keywords
- I
- Dopamine transporter
- KUC-25019
- SPET
- Tropane analog
ASJC Scopus subject areas
- Clinical Biochemistry
- Molecular Medicine
- Analytical Chemistry
- Organic Chemistry
- Drug Discovery
- Pharmacology
Fingerprint
Dive into the research topics of 'Radiosynthesis of [123I]N-(3-iodoprop-(2E)-enyl)-2α-(imino-methyl)-3 β-(3′,4′-dichlorophenyl) nortropane as a potential SPET tracer for dopamine transporter'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS